Recent Finacing
Recent Raise
Eigen Therapeutics develops priming therapies that upregulate target protein expression in cancer cells and uses a proprietary high-throughput platform—combinatorial screening, robotics, lab ops software, and machine learning—focusing on hematologic malignancies.
